BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19389215)

  • 1. Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.
    Meyer-Monard S; Passweg J; Siegler U; Kalberer C; Koehl U; Rovó A; Halter J; Stern M; Heim D; Alois Gratwohl JR; Tichelli A
    Transfusion; 2009 Feb; 49(2):362-71. PubMed ID: 19389215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation.
    Passweg JR; Tichelli A; Meyer-Monard S; Heim D; Stern M; Kühne T; Favre G; Gratwohl A
    Leukemia; 2004 Nov; 18(11):1835-8. PubMed ID: 15457184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
    Dykes JH; Toporski J; Juliusson G; Békássy AN; Lenhoff S; Lindmark A; Scheding S
    Transfusion; 2007 Nov; 47(11):2134-42. PubMed ID: 17958543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
    Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
    Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
    Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence factors of reconstitution of killer cell immunoglobulin-like receptor on NK cells following non-T-cell-depleted haploidentical hematopoietic stem cell transplantation].
    Zhao XY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):103-6. PubMed ID: 17650670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of natural killer cells in hematopoetic stem cell transplantation.
    Passweg JR; Stern M; Koehl U; Uharek L; Tichelli A
    Bone Marrow Transplant; 2005 Apr; 35(7):637-43. PubMed ID: 15654351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of high-stringency CD8 depletion of donor leukocyte infusions after allogeneic hematopoietic stem cell transplantation.
    Orti G; Lowdell M; Fielding A; Samuel E; Pang K; Kottaridis P; Morris E; Thomson K; Peggs K; Mackinnon S; Chakraverty R
    Transplantation; 2009 Dec; 88(11):1312-8. PubMed ID: 19996931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
    Lang P; Pfeiffer M; Müller I; Schumm M; Ebinger M; Koscielniak E; Feuchtinger T; Föll J; Martin D; Handgretinger R
    Klin Padiatr; 2006; 218(6):321-6. PubMed ID: 17080334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation.
    Passweg JR; Koehl U; Uharek L; Meyer-Monard S; Tichelli A
    Best Pract Res Clin Haematol; 2006; 19(4):811-24. PubMed ID: 16997185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.
    Koehl U; Sörensen J; Esser R; Zimmermann S; Grüttner HP; Tonn T; Seidl C; Seifried E; Klingebiel T; Schwabe D
    Blood Cells Mol Dis; 2004; 33(3):261-6. PubMed ID: 15528141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference.
    Locatelli F; Pende D; Maccario R; Mingari MC; Moretta A; Moretta L
    Clin Immunol; 2009 Nov; 133(2):171-8. PubMed ID: 19481979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children.
    Lang P; Pfeiffer M; Handgretinger R; Schumm M; Demirdelen B; Stanojevic S; Klingebiel T; Köhl U; Kuci S; Niethammer D
    Bone Marrow Transplant; 2002 Mar; 29(6):497-502. PubMed ID: 11960269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.
    Schumm M; Handgretinger R; Pfeiffer M; Feuchtinger T; Kuci S; Faul C; Vogel W; Bethge W; Lang P
    Cytotherapy; 2006; 8(5):465-72. PubMed ID: 17050251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.